Isopropylbenzene

Isopropylbenzene

SCHEMBL4795494

CC(C)c1ccccc1.CC(C)c1ccccc1.OO

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 2/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
ADRA2A P08913 1/20 0.52
HIF1A Q16665 1/20 0.52
ALDH1A1 P00352 2/20 0.50
CYP2D6 P10635 3/20 0.48
CHRM2 P08172 1/20 0.48
ADRA1A P35348 1/20 0.48
RGS12 O14924 1/20 0.48
GLA P06280 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
ALOX12 P18054 1/20 0.48
NFKB1 P19838 1/20 0.48
HTR2A P28223 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropylbenzene SCHEMBL23421101 1.00 ADRA2C (0.52) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL16627 1.00 ADRA2C (0.52) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL30804544 1.00 ADRA2C (0.52) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL6320513 1.00 ADRA2C (0.52) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL18614726 1.00 ADRA2C (0.52) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL4087648 0.97 ADRA2C (0.50) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL28421110 0.97 ADRA2C (0.50) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL11051581 0.97 ADRA2C (0.50) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL23501477 0.97 ALDH1A1 (0.54) ADRA2CKDM4ELMNAADRA2AHIF1A
Isopropylbenzene SCHEMBL7601546 0.97 ADRA2C (0.50) ADRA2CKDM4ELMNAADRA2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116924430-A Micro-mesoporous composite titanium-containing borosilicate molecular sieve, and preparation method and application thereof 华东师范大学 2023-10-24 CN claimed
CN-119752150-A Polymer-based dielectric composite material and preparation method and application thereof 南方科技大学 2025-04-04 CN disclosed
CN-113891911-B Rubber composition, sulfide, and vulcanized molded article 电化株式会社 2024-10-29 CN disclosed
CN-115819308-B Preparation method of poly-hydrogen peroxide cumene 万华化学集团股份有限公司 2024-03-29 CN disclosed
EP-4318778-A1 SEPARATOR, ELECTROCHEMICAL APPARATUS INCLUDING SEPARATOR, AND ELECTRONIC APPARATUS Ningde Amperex Technology Limited (CN) 2024-02-07 EP disclosed
US-20240030551-A1 SEPARATOR, ELECTROCHEMICAL DEVICE CONTAINING SAME, AND ELECTRONIC DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-01-25 US disclosed
CN-116924430-A Micro-mesoporous composite titanium-containing borosilicate molecular sieve, and preparation method and application thereof 华东师范大学 2023-10-24 CN disclosed
CN-110050048-A The reactive two component adhesive system of heat-resisting moist form membrane with improvement 德莎欧洲股份公司 2019-07-23 CN disclosed
CN-109851467-A The method for preparing cumene 巴杰许可有限责任公司 2019-06-07 CN disclosed
CN-106573862-A The optimization of o-sulfonated phenol production for cumene hydroperoxide cleavage 沙特基础工业全球技术有限公司 2017-04-19 CN disclosed
US-7462728-B2 Diepoxide derivatives of N,N*-disubstituted disulfonamides PEWS R GARTH 2008-12-09 US disclosed
CN-101128518-A Process for producing coagulated latex particles KANEGAFUCHI CHEMICAL IND (JP) 2008-02-20 CN disclosed
US-7153925-B2 Condensation polymers from N, N*-disubstituted disulfonamides PEWS R GARTH 2006-12-26 US disclosed
US-7141684-B2 Diepoxide derivatives of diallyl phenolics PEWS R GARTH 2006-11-28 US disclosed
US-20060128924-A1 Novel condensation polymers from N, N*-disubstituted disulfonamides PEWS R G 2006-06-15 US disclosed
US-20060128978-A1 Diepoxide derivatives of N, N*-disubstituted disulfonamides PEWS R G 2006-06-15 US disclosed
CN-1747920-A Method for purifying phenol SHELL OIL CO (NL) 2006-03-15 CN disclosed
US-20050090673-A1 Novel diepoxide derivatives of diallyl phenolics PEWS R G (US) 2005-04-28 US disclosed
US-6670474-B2 Such as bis-1,2-(2-(2,3-epoxypropyl)phenoxy)ethane; chemical intermediates for formation of epoxy resins PEWS R GARTH (US) 2003-12-30 US disclosed
US-20020151731-A1 Novel epoxide derivatives of allylarylphenols PEWS R GARTH (US) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090673-A1 Novel diepoxide derivatives of diallyl phenolics EBP, EED, ESR2 ADRA2C 2616/4885KDM4E 293/4885LMNA 3547/4885
US-20020151731-A1 Novel epoxide derivatives of allylarylphenols EPHX2, CBR3, CYP4X1 ADRA2C 221/4885KDM4E 200/4885LMNA 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.